AF.50 SAFETY AND CLINICAL EFFICACY OF THE DOUBLE SWITCH FROM ORIGINATOR INFLIXIMAB TO BIOSIMILARS CT-P13 AND SB2 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES (SCESICS): A MULTICENTER COHORT STUDY. (September 2021)

Record Type:: Journal Article
Title:: AF.50 SAFETY AND CLINICAL EFFICACY OF THE DOUBLE SWITCH FROM ORIGINATOR INFLIXIMAB TO BIOSIMILARS CT-P13 AND SB2 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES (SCESICS): A MULTICENTER COHORT STUDY. (September 2021)
Main Title:: AF.50 SAFETY AND CLINICAL EFFICACY OF THE DOUBLE SWITCH FROM ORIGINATOR INFLIXIMAB TO BIOSIMILARS CT-P13 AND SB2 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES (SCESICS): A MULTICENTER COHORT STUDY
Authors:: Mazza, S.
Piazza O Sed, N.
Conforti, F.S.
Fascì, A.
Casini, V.
Ricci, C.
Munari, F.
Pirola, L.
Invernizzi, P.
Girelli, C.
Lupinacci, G.
Pastorelli, L.
Cavallaro, F.
Ferraris, L.
Colucci, A.
Amato, A.
Tontini, G.E.
Vecchi, M.
Fiorino, G.
Caprioli, F.
Abstract:
Is Part Of:: Digestive and liver disease. Volume 53(2021)Supplement 3
Journal:: Digestive and liver disease
Issue:: Volume 53(2021)Supplement 3
Issue Display:: Volume 53, Issue 3 (2021)
Year:: 2021
Volume:: 53
Issue:: 3
Issue Sort Value:: 2021-0053-0003-0000
Page Start:: S159
Page End:
Publication Date:: 2021-09
Subjects:: Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
616.33005
Journal URLs:: http://www.sciencedirect.com/science/journal/15908658 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S1590-8658(21)00613-7 ↗
Languages:: English
ISSNs:: 1590-8658
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3588.345600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 19709.xml